BIODESIX, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
BIODESIX, INC. (BDSX) had Warrants Not Settleable in Cash, Fair Value Disclosure of $300.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-14.
Discontinued › Notes
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2022-03-14
- 2021-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $300.00K.
- 2021-09-30: Warrants Not Settleable in Cash, Fair Value Disclosure $300.00K.
- 2021-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $300.00K.
- 2021-03-31: Warrants Not Settleable in Cash, Fair Value Disclosure $300.00K.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $300.00K 10-K · filed 2022-03-14 |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $300.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $300.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $300.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |